Dimensional Fund Advisors
FLXN

Dimensional Fund Advisors’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Dimensional Fund Advisors’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-13,142
Closed -$103K – 3375
2020
Q1 		$103K Sell
13,142
-658
-5% -$9.91K ﹤0.01% 3270
2019
Q4 		$286K Hold
13,800
– – ﹤0.01% 3217
2019
Q3 		$189K Sell
13,800
-81,008
-85% -$961K ﹤0.01% 3290
2019
Q2 		$1.17M Buy
94,808
+46,957
+98% +$542K ﹤0.01% 3024
2019
Q1 		$597K Hold
47,851
– – ﹤0.01% 3133
2018
Q4 		$542K Hold
47,851
– – ﹤0.01% 3132
2018
Q3 		$895K Buy
+47,851
New +$1.1M ﹤0.01% 3088

Other funds holding FLXN

MVP
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

Dimensional Fund Advisors's FLXN Position: Q2 2020 in Review

Dimensional Fund Advisors sold out of Flexion Therapeutics, Inc. (FLXN) in Q2 2020, closing a stake of 13,142 shares — an estimated $103K sold.

Dimensional Fund Advisors first reported a position in FLXN in Q3 2018 and held it in 7 quarters. The position peaked at $1.17M in Q2 2019. 125 funds tracked by Wall St. Rank hold FLXN as of Q2 2020.

  • Dimensional Fund Advisors reported no remaining Flexion Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
  • Dimensional Fund Advisors sold 13,142 Flexion Therapeutics, Inc. shares in Q2 2020, an estimated $103K.
  • Dimensional Fund Advisors first reported a position in Flexion Therapeutics, Inc. in Q3 2018 and held it in 7 quarters.
  • Dimensional Fund Advisors's Flexion Therapeutics, Inc. position peaked at $1.17M in Q2 2019.
  • 125 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q2 2020.

Based on Dimensional Fund Advisors's 13F filing for Q2 2020, filed 13 Aug 2020.